Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • Big pharma
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • Big pharma
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • Cross-Sector Research
    • AMR Research Programme
    • AMR Research Programme
  • News
  • Our team
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Photo of: Bram Wagner
Investor Engagement Officer

Bram Wagner

Bram is an Investor Engagement Officer at the Access to Medicine Foundation. He supports the Foundation’s ongoing engagement with institutional investors. The Foundation works with a variety of stakeholder groups, including healthcare analysts and ESG professionals, to improve their knowledge of how pharmaceutical companies manage risks and opportunities related to access to medicine. So far, more than 120 institutional investors have pledged their support by signing the Access to Medicine Index Investor Statement. Together, these investors manage assets in excess of USD 21 trillion.

Bram is a pharmacist by training, and holds a Master’s degree in Pharmacy from Utrecht University School of Pharmacy. He completed his Master’s thesis at the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation, where he contributed to the analysis of the robustness of an adapted Sustainable Development Goal indicator 3.b.3., which measures access to medicine for children.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved